Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells
Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells is a paper indexed in PICO Portal from OpenAlex.
How many citations does Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells have?
Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells has 40 citations in the OpenAlex counts PICO Portal stores.
When was Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells published?
Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells has 2017 year in the PICO Portal index.
What is the open-access status of Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells?
Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells has gold oa status in the PICO Portal index.
What is the DOI of Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells?
The DOI for Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells is on the source record.
What is the PMID of Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells?
The PMID for Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells is on the source record.
What is the OpenAlex record for Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells?
The OpenAlex for Transcriptome-based repurposing of apigenin as a potential anti-fibrotic agent targeting hepatic stellate cells is on the source record.